PRACTICE
Below are de-identified cases from our centers’ practice: the site, the method, the dose and what follow-up showed. Patient personal data is never published.
METHOD
The figures below come from international literature on radiosurgery as a method itself — not from the results of our centers
five-year survival in early lung cancer
local control for spine tumors
five-year progression-free survival in prostate cancer
publications on radiosurgery in the international literature
CLINICAL EXAMPLES
De-identified: only the site, method, dose and follow-up results are kept
Initial regimen — PGTV 6 Gy × 3 fractions. After three fractions the right lung re-expanded and the plan was rebuilt: PGTV 4 Gy × 12 fractions.
The atelectasis resolved during radiotherapy; the rest of the treatment proceeded on the adjusted plan — without interruption and without changing the method.
The patient declined resection. Based on multimodal imaging, the lesion was irradiated stereotactically — no puncture and no anesthesia.
A partial response was still present at 7 months; one year after radiotherapy no local recurrence was detected.
Surgery was contraindicated because the tumor had grown into the vessels. Palliative radiotherapy and 6 courses of gemcitabine with nab-paclitaxel were given; later — radiotherapy of the single metastasis in segment S1 of the liver over 5 fractions.
On imaging the pancreatic tumor is in durable remission; follow-up PET-CT showed no recurrence or metastasis. Overall survival — 3 years; during that time a radical operation for thyroid cancer was performed.
Surgery was not possible. The tumor thrombus was irradiated first to preserve the remaining liver function, then SCART was used — a high dose to the core of the tumor with a reduced dose at the periphery.
The tumor shrank by about 90%, the tumor thrombus almost disappeared and the abdominal bloating resolved. The AFP tumor marker returned to normal, compensatory hypertrophy of the left lobe developed and liver function improved.
The L4 metastasis was irradiated on a linear accelerator (GTV 8 Gy × 5, CTV 6 Gy × 5). The primary tumor was treated on the CyberKnife, 7,25 Gy × 5, with the dose-painting technique and tracking by fiducial markers.
The pain in the right lower limb resolved completely and the PSA level dropped quickly.
Three endovascular embolizations were performed over a year and a half, but the nidus could not be closed completely and the hemorrhages recurred. Stereotactic radiotherapy was delivered.
Six months later MRI and MR angiography showed a marked reduction of the nidus: most of the pathological vessels were closed and no new hemorrhage was detected.
The response to treatment is individual: a similar diagnosis does not mean the same result. Decisions on method and dose are made by the board based on your documents and examination data — before treatment starts.
Send us your medical records — we will first check whether a similar treatment path exists
WhatsApp:+996 880 470 606
